Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.485 USD | +7.23% | +8.07% | -32.30% |
11/06 | Transcript : Vistagen Therapeutics, Inc., Q4 2024 Earnings Call, Jun 11, 2024 | |
11/06 | Vistagen Therapeutics, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Sales 2025 * | 2L 1.65Cr | Sales 2026 * | 3L 2.2Cr | Capitalization | 8.78Cr 732.96Cr |
---|---|---|---|---|---|
Net income 2025 * | -6.7Cr -559.12Cr | Net income 2026 * | -8.2Cr -684.29Cr | EV / Sales 2025 * | 138 x |
Net cash position 2025 * | 6.06Cr 505.71Cr | Net cash position 2026 * | - 0 | EV / Sales 2026 * | 333 x |
P/E ratio 2025 * |
-1.49
x | P/E ratio 2026 * |
-1.72
x | Employees | 40 |
Yield 2025 * |
-
| Yield 2026 * |
-
| Free-Float | 99.79% |
Latest transcript on Vistagen Therapeutics, Inc.
1 day | +7.23% | ||
1 week | +8.07% | ||
Current month | -9.84% | ||
1 month | -14.29% | ||
3 months | -23.85% | ||
6 months | -32.30% | ||
Current year | -32.30% |
Managers | Title | Age | Since |
---|---|---|---|
Shawn Singh
CEO | Chief Executive Officer | 61 | 01/00/01 |
Cynthia Anderson
DFI | Director of Finance/CFO | 55 | 21/23/21 |
Joshua Prince
COO | Chief Operating Officer | 54 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jon Saxe
BRD | Director/Board Member | 88 | 01/00/01 |
Jerry Gin
BRD | Director/Board Member | 81 | 01/16/01 |
Shawn Singh
CEO | Chief Executive Officer | 61 | 01/00/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 18 M€ | +4.51% | - |
Date | Price | Change | Volume |
---|---|---|---|
28/24/28 | 3.49 | +7.38% | 92 089 |
26/24/26 | 3.25 | -2.11% | 52,108 |
25/24/25 | 3.32 | +2.79% | 83,567 |
24/24/24 | 3.23 | -3.58% | 92,750 |
21/24/21 | 3.35 | +4.04% | 118,845 |
Delayed Quote Nasdaq, June 28, 2024 at 12:52 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.30% | 8.78Cr | |
+16.42% | 12TCr | |
+19.33% | 12TCr | |
+21.22% | 2.66TCr | |
-23.78% | 1.99TCr | |
-17.47% | 1.63TCr | |
-45.95% | 1.55TCr | |
-18.35% | 1.55TCr | |
+63.96% | 1.48TCr | |
+2.09% | 1.37TCr |
- Stock Market
- Equities
- VTGN Stock